img

Global Gene Therapy in Cardiovascular Disorder Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Gene Therapy in Cardiovascular Disorder Market Research Report 2024

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
According to MRAResearch’s new survey, global Gene Therapy in Cardiovascular Disorder market is projected to reach US$ 1351.3 million in 2033, increasing from US$ 178 million in 2022, with the CAGR of 21.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Therapy in Cardiovascular Disorder market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gene Therapy in Cardiovascular Disorder market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Renovacor
Gene Biotherapeutics
AskBio
Human Stem Cells Institute
Novartis
Segment by Type
Viral Gene Therapy
Non-viral Gene Therapy

Segment by Application


Heart Disease
Vascular Disease
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Gene Therapy in Cardiovascular Disorder report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Viral Gene Therapy
1.2.3 Non-viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy in Cardiovascular Disorder Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Heart Disease
1.3.3 Vascular Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy in Cardiovascular Disorder Market Perspective (2018-2033)
2.2 Gene Therapy in Cardiovascular Disorder Growth Trends by Region
2.2.1 Global Gene Therapy in Cardiovascular Disorder Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gene Therapy in Cardiovascular Disorder Historic Market Size by Region (2018-2023)
2.2.3 Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Region (2024-2033)
2.3 Gene Therapy in Cardiovascular Disorder Market Dynamics
2.3.1 Gene Therapy in Cardiovascular Disorder Industry Trends
2.3.2 Gene Therapy in Cardiovascular Disorder Market Drivers
2.3.3 Gene Therapy in Cardiovascular Disorder Market Challenges
2.3.4 Gene Therapy in Cardiovascular Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy in Cardiovascular Disorder Players by Revenue
3.1.1 Global Top Gene Therapy in Cardiovascular Disorder Players by Revenue (2018-2023)
3.1.2 Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy in Cardiovascular Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy in Cardiovascular Disorder Revenue
3.4 Global Gene Therapy in Cardiovascular Disorder Market Concentration Ratio
3.4.1 Global Gene Therapy in Cardiovascular Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy in Cardiovascular Disorder Revenue in 2022
3.5 Gene Therapy in Cardiovascular Disorder Key Players Head office and Area Served
3.6 Key Players Gene Therapy in Cardiovascular Disorder Product Solution and Service
3.7 Date of Enter into Gene Therapy in Cardiovascular Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy in Cardiovascular Disorder Breakdown Data by Type
4.1 Global Gene Therapy in Cardiovascular Disorder Historic Market Size by Type (2018-2023)
4.2 Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Type (2024-2033)
5 Gene Therapy in Cardiovascular Disorder Breakdown Data by Application
5.1 Global Gene Therapy in Cardiovascular Disorder Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gene Therapy in Cardiovascular Disorder Market Size (2018-2033)
6.2 North America Gene Therapy in Cardiovascular Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Gene Therapy in Cardiovascular Disorder Market Size by Country (2018-2023)
6.4 North America Gene Therapy in Cardiovascular Disorder Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy in Cardiovascular Disorder Market Size (2018-2033)
7.2 Europe Gene Therapy in Cardiovascular Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2018-2023)
7.4 Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size (2018-2033)
8.2 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy in Cardiovascular Disorder Market Size (2018-2033)
9.2 Latin America Gene Therapy in Cardiovascular Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Gene Therapy in Cardiovascular Disorder Market Size by Country (2018-2023)
9.4 Latin America Gene Therapy in Cardiovascular Disorder Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size (2018-2033)
10.2 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Renovacor
11.1.1 Renovacor Company Detail
11.1.2 Renovacor Business Overview
11.1.3 Renovacor Gene Therapy in Cardiovascular Disorder Introduction
11.1.4 Renovacor Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
11.1.5 Renovacor Recent Development
11.2 Gene Biotherapeutics
11.2.1 Gene Biotherapeutics Company Detail
11.2.2 Gene Biotherapeutics Business Overview
11.2.3 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Introduction
11.2.4 Gene Biotherapeutics Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
11.2.5 Gene Biotherapeutics Recent Development
11.3 AskBio
11.3.1 AskBio Company Detail
11.3.2 AskBio Business Overview
11.3.3 AskBio Gene Therapy in Cardiovascular Disorder Introduction
11.3.4 AskBio Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
11.3.5 AskBio Recent Development
11.4 Human Stem Cells Institute
11.4.1 Human Stem Cells Institute Company Detail
11.4.2 Human Stem Cells Institute Business Overview
11.4.3 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Introduction
11.4.4 Human Stem Cells Institute Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
11.4.5 Human Stem Cells Institute Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Gene Therapy in Cardiovascular Disorder Introduction
11.5.4 Novartis Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
11.5.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-viral Gene Therapy
Table 4. Global Gene Therapy in Cardiovascular Disorder Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Gene Therapy in Cardiovascular Disorder Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Gene Therapy in Cardiovascular Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gene Therapy in Cardiovascular Disorder Market Share by Region (2018-2023)
Table 8. Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Gene Therapy in Cardiovascular Disorder Market Share by Region (2024-2033)
Table 10. Gene Therapy in Cardiovascular Disorder Market Trends
Table 11. Gene Therapy in Cardiovascular Disorder Market Drivers
Table 12. Gene Therapy in Cardiovascular Disorder Market Challenges
Table 13. Gene Therapy in Cardiovascular Disorder Market Restraints
Table 14. Global Gene Therapy in Cardiovascular Disorder Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gene Therapy in Cardiovascular Disorder Market Share by Players (2018-2023)
Table 16. Global Top Gene Therapy in Cardiovascular Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Cardiovascular Disorder as of 2022)
Table 17. Ranking of Global Top Gene Therapy in Cardiovascular Disorder Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene Therapy in Cardiovascular Disorder Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy in Cardiovascular Disorder Product Solution and Service
Table 21. Date of Enter into Gene Therapy in Cardiovascular Disorder Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy in Cardiovascular Disorder Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Type (2018-2023)
Table 25. Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Type (2024-2033)
Table 27. Global Gene Therapy in Cardiovascular Disorder Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Application (2018-2023)
Table 29. Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Application (2024-2033)
Table 31. North America Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Gene Therapy in Cardiovascular Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gene Therapy in Cardiovascular Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Gene Therapy in Cardiovascular Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gene Therapy in Cardiovascular Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 46. Renovacor Company Detail
Table 47. Renovacor Business Overview
Table 48. Renovacor Gene Therapy in Cardiovascular Disorder Product
Table 49. Renovacor Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023) & (US$ Million)
Table 50. Renovacor Recent Development
Table 51. Gene Biotherapeutics Company Detail
Table 52. Gene Biotherapeutics Business Overview
Table 53. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product
Table 54. Gene Biotherapeutics Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023) & (US$ Million)
Table 55. Gene Biotherapeutics Recent Development
Table 56. AskBio Company Detail
Table 57. AskBio Business Overview
Table 58. AskBio Gene Therapy in Cardiovascular Disorder Product
Table 59. AskBio Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023) & (US$ Million)
Table 60. AskBio Recent Development
Table 61. Human Stem Cells Institute Company Detail
Table 62. Human Stem Cells Institute Business Overview
Table 63. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product
Table 64. Human Stem Cells Institute Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023) & (US$ Million)
Table 65. Human Stem Cells Institute Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Gene Therapy in Cardiovascular Disorder Product
Table 69. Novartis Revenue in Gene Therapy in Cardiovascular Disorder Business (2018-2023) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy in Cardiovascular Disorder Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Gene Therapy in Cardiovascular Disorder Market Share by Type: 2022 VS 2033
Figure 3. Viral Gene Therapy Features
Figure 4. Non-viral Gene Therapy Features
Figure 5. Global Gene Therapy in Cardiovascular Disorder Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Gene Therapy in Cardiovascular Disorder Market Share by Application: 2022 VS 2033
Figure 7. Heart Disease Case Studies
Figure 8. Vascular Disease Case Studies
Figure 9. Gene Therapy in Cardiovascular Disorder Report Years Considered
Figure 10. Global Gene Therapy in Cardiovascular Disorder Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Gene Therapy in Cardiovascular Disorder Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Gene Therapy in Cardiovascular Disorder Market Share by Region: 2022 VS 2033
Figure 13. Global Gene Therapy in Cardiovascular Disorder Market Share by Players in 2022
Figure 14. Global Top Gene Therapy in Cardiovascular Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Cardiovascular Disorder as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy in Cardiovascular Disorder Revenue in 2022
Figure 16. North America Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Gene Therapy in Cardiovascular Disorder Market Share by Country (2018-2033)
Figure 18. United States Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Gene Therapy in Cardiovascular Disorder Market Share by Country (2018-2033)
Figure 22. Germany Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Share by Region (2018-2033)
Figure 30. China Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Gene Therapy in Cardiovascular Disorder Market Share by Country (2018-2033)
Figure 38. Mexico Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Share by Country (2018-2033)
Figure 42. Turkey Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Renovacor Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
Figure 45. Gene Biotherapeutics Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
Figure 46. AskBio Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
Figure 47. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries